Sign inJoin waitlistJoin the waitlist

Joshua Lang

Program Co-Director · University of Wisconsin Hospitals and Clinics

Credentials: · · · ·

History

University of Wisconsin Hospitals and Clinics
Present
tumor microenvironment program · UW Carbone Cancer Center
Present
precision medicine molecular tumor board Department · UW Carbone Cancer Center
Present

University of Wisconsin Hospitals and Clinics
2011–2012
Fellowship in Medical Oncology
2009–2011
Internal Medicine
University of Wisconsin Hospitals and Clinics
2006–2009
University of Illinois College of Medicine
2002–2006

Research

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2019 · 1,050 citations
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2023 · 555 citations
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket…
Annals of Oncology · 2021 · 354 citations

Shuang Zhao
33 papers · 5 as a resident
David Kosoff
20 papers · 9 as a fellow
Rana McKay
16 papers · 6 as a resident
Marina Sharifi
15 papers · 11 as a resident
Andrew Armstrong
13 papers
Christos Kyriakopoulos
13 papers
Felix Feng
13 papers
David Jarrard
12 papers
HE
Hamid Emamekhoo
12 papers
Nan Sethakorn
12 papers · 6 as a fellow
NR
Nicholas Rydzewski
12 papers · 2 as a resident
Daniel Spratt
11 papers

Grants

The Molecular Drivers and Therapeutic Susceptibilities in Lineage State Transitions of Metastatic Prostate Cancer
National Cancer Institute · P01
Contact PI · $5.1M · University of Wisconsin-Madison
2025–2030
University of Wisconsin Prostate SPORE
National Cancer Institute · P50
Project lead · $2M · University of Wisconsin-Madison
2023–2030
Cell-Free DNA Fragmentomics as Prognostic and Treatment Resistance Biomarkers in Metastatic Castration-Resistant Prostate Cancer
National Cancer Institute · R01
PI · $1.3M · University of Wisconsin-Madison
2025–2029
Molecular Regulation and Expression of Trop-2 in Advanced Prostate Cancer: Identifying Optimal Therapeutic Niches
National Cancer Institute · R01
Contact PI · $2.6M · University of Wisconsin-Madison
2023–2028

Clinical trials

Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy
Principal investigator · Active not recruiting · Phase 2
University of Wisconsin, Madison
2018–2027
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
Site PI · Recruiting
Duke University
2024–2027
Using FAPI PET/MRI to Evaluate Prostate Cancer
Sub-investigator · Recruiting · Phase 2
University of Wisconsin, Madison
2026–2027